| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |